Your browser is no longer supported. Please, upgrade your browser.
SIAL Sigma-Aldrich Corporation monthly Stock Chart
SIAL [NASD]
Sigma-Aldrich Corporation
IndexS&P 500 P/E33.53 EPS (ttm)4.16 Insider Own0.30% Shs Outstand119.66M Perf Week0.10%
Market Cap16.69B Forward P/E29.55 EPS next Y4.72 Insider Trans-10.89% Shs Float118.94M Perf Month0.60%
Income500.00M PEG5.50 EPS next Q1.11 Inst Own82.80% Short Float1.21% Perf Quarter0.87%
Sales2.77B P/S6.02 EPS this Y2.70% Inst Trans-2.73% Short Ratio1.40 Perf Half Y1.95%
Book/sh26.39 P/B5.29 EPS next Y6.14% ROA12.30% Target Price121.50 Perf Year37.53%
Cash/sh7.91 P/C17.64 EPS next 5Y6.10% ROE16.00% 52W Range98.37 - 140.03 Perf YTD1.95%
Dividend0.92 P/FCF42.25 EPS past 5Y8.30% ROI14.10% 52W High-0.39% Beta0.72
Dividend %0.66% Quick Ratio4.00 Sales past 5Y5.30% Gross Margin51.40% 52W Low41.80% ATR0.36
Employees9400 Current Ratio5.90 Sales Q/Q-1.90% Oper. Margin25.90% RSI (14)62.14 Volatility0.13% 0.23%
OptionableYes Debt/Eq0.09 EPS Q/Q-1.00% Profit Margin18.00% Rel Volume0.72 Prev Close139.44
ShortableYes LT Debt/Eq0.09 EarningsJul 23 BMO Payout21.90% Avg Volume1.03M Price139.48
Recom2.80 SMA200.30% SMA500.43% SMA2002.24% Volume735,232 Change0.03%
Sep-22-14Reiterated MKM Partners Buy $95 → $140
Apr-25-14Reiterated Mizuho Neutral $85 → $95
Feb-07-14Reiterated UBS Sell $74 → $82
Oct-22-13Reiterated Mizuho Neutral $80 → $85
Sep-20-13Downgrade Robert W. Baird Outperform → Neutral
Jul-23-13Reiterated Mizuho Neutral $75 → $80
Apr-25-13Reiterated Mizuho Neutral $70 → $75
Feb-11-13Downgrade UBS Neutral → Sell $76 → $70
Feb-08-13Reiterated Mizuho Neutral $68 → $70
Feb-10-11Downgrade Longbow Buy → Neutral
Jan-12-11Downgrade KeyBanc Capital Mkts Buy → Hold
Oct-22-10Reiterated UBS Buy $68 → $70
Oct-22-10Reiterated Longbow Buy $65 → $72
Apr-14-10Upgrade UBS Neutral → Buy
Feb-11-10Upgrade Robert W. Baird Neutral → Outperform $60
Nov-06-09Initiated Jefferies & Co Hold $54
Aug-26-09Reiterated KeyBanc Capital Mkts Buy $54 → $60
Apr-24-09Reiterated UBS Neutral $40 → $44
Feb-04-09Downgrade Longbow Buy → Neutral
Dec-15-08Reiterated Robert W. Baird Neutral $46 → $40
Jun-29-15 11:50AM  Hedge Funds Carlson Capital and Adage Capital Heavily Invest In The Same Stocks at Insider Monkey
Jun-17-15 05:45PM  Sigma-Aldrich's Buyout by Merck KGaA Gets EC Clearance - Analyst Blog
Jun-15-15 03:21PM  SIGMA ALDRICH CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:58PM  Will Merck (MKGAY) Stock be Helped by EC Approval of $17 Billion Sigma-Aldrich Deal? at TheStreet
02:49PM  [$$] EU Approves Merck KGaA $17 Billion Purchase of Sigma-Aldrich at The Wall Street Journal
02:33PM  Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives Approval from European Union Regulators and from Chinese Ministry of Commerce PR Newswire
01:40PM  European Commission approves Merck's $17 bln Sigma-Aldrich buy Reuters
Jun-11-15 07:00AM  Sigma-Aldrich® Named to Newsweek's 2015 Green Rankings PR Newswire
05:49AM  South Korea cuts rates as MERS clouds outlook; 10th patient dies Reuters
Jun-10-15 05:05PM  Sigma-Aldrich's Cerilliant Launches New Antifungal Agents - Analyst Blog
Jun-09-15 07:00AM  Cerilliant Introduces Snap-N-Spike® Stable-Labeled Internal Standards of Antifungal Agents PR Newswire
Jun-04-15 07:00AM  Sigma-Aldrich Expands Analytical Portfolio with National Institute of Standards and Technology Standard Reference Materials PR Newswire
Jun-03-15 02:20PM  Sigma-Aldrich Partners with XCell for Advanced Neural Cells - Analyst Blog
08:09AM  Why Sigma-Aldrichs stock is falling
Jun-02-15 07:00AM  Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells PR Newswire
Jun-01-15 02:40PM  Sigma-Aldrich (SIAL) Hits a New 52-Week High of $140.03 - Analyst Blog
May-19-15 03:15PM  Merck KGaA profits decline on Sigma-Aldrich acquisition costs at bizjournals.com
06:06AM  Merck Profit Pressured by M&A Financing at The Wall Street Journal
05:04AM  Merck KGaA says to overcome EU concerns on Sigma-Aldrich deal Reuters
May-13-15 01:04PM  SIGMA ALDRICH CORP Financials
12:30PM  Sigma-Aldrich's SAFC Completes St. Louis Facility Expansion - Analyst Blog
May-12-15 07:00AM  SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling PR Newswire
07:00AM  SAFC Completes ADC Commercial Manufacturing Capacity Expansion in St. Louis PR Newswire
May-07-15 03:35PM  Sigma-Aldrich Q1 Earnings and Revenues Miss Estimates - Analyst Blog
09:06AM  SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
08:43AM  Sigma-Aldrich (SIAL) Misses Q1 Earnings and Revenue Estimates - Tale of the Tape
07:21AM  Sigma-Aldrich misses Street 1Q forecasts
07:07AM  Q1 2015 Sigma-Aldrich Corp Earnings Release - Before Market Open
07:00AM  Sigma-Aldrich (NASDAQ - SIAL) Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend. PR Newswire
May-06-15 07:00AM  Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology PR Newswire
May-05-15 03:02PM  SIGMA ALDRICH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Apr-29-15 11:41AM  Annual Report & Accounts 2014 and Notice of Meeting at noodls
Apr-27-15 06:52PM  Energizer announces new board members for upcoming split at bizjournals.com
Apr-21-15 02:52PM  Will Sigma-Aldrich (SIAL) Miss Earnings Estimates in Q1? - Analyst Blog
07:20AM  St. Louis companies among the 'best corporate citizens' at bizjournals.com
07:10AM  BioReliance Licenses B-CLEAR® Technology from Qualyst Transporter Solutions for Drug Transporter Studies at noodls
07:00AM  BioReliance Licenses B-CLEAR® Technology from Qualyst Transporter Solutions for Drug Transporter Studies PR Newswire
Apr-20-15 03:44PM  Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List at noodls
03:34PM  Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List PR Newswire
Apr-18-15 11:18AM  Merck aims to quickly repay up to $5 bln in loans -CFO in Boersen-Zeitung Reuters
Apr-17-15 04:30PM  Sigma-Aldrich (SIAL) Opens New Cell Culture Technical Center - Analyst Blog
07:20AM  Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia at noodls
07:00AM  Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia PR Newswire
Apr-16-15 11:00PM  Sigma-Aldrich(R) Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia PR Newswire
01:05PM  Sigma-Aldrich exec leaving to head medical packaging company at bizjournals.com
Apr-15-15 11:02AM  SIGMA ALDRICH CORP Files SEC form 8-K, Change in Directors or Principal Officers
Apr-13-15 03:37PM  Walker signs deal with German researchers, meets with Merck
Apr-10-15 11:00AM  TLT.V: Health Canada provides guidance on clinical trial protocol for Phase Ib Clinical Trial
Apr-08-15 09:40AM  Sigma-Aldrich Unveils New EX-CELL Advanced Product Line - Analyst Blog
Apr-07-15 07:17AM  SAFC Launches New EX-CELL® Advanced Products for Scalable, Efficient Biopharmaceutical Manufacturing at noodls
07:00AM  SAFC Launches New EX-CELL® Advanced Products for Scalable, Efficient Biopharmaceutical Manufacturing PR Newswire
Mar-31-15 11:55AM  PDMR SHAREHOLDING at noodls
11:55AM  DIRECTORS/PDMR SHAREHOLDING at noodls
Mar-23-15 04:27PM  Conatus Pharmaceuticals and BioReliance Present Key Emricasan Preclinical Safety Results at Society of Toxicology Annual Meeting at noodls
04:01PM  Conatus Pharmaceuticals and BioReliance Present Key Emricasan Preclinical Safety Results at Society of Toxicology Annual Meeting GlobeNewswire
Mar-20-15 03:58PM  Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta at noodls
03:00PM  Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta PR Newswire
11:51AM  Sigma-Aldrich (SIAL) Inks Distribution Agreement with Roche - Analyst Blog
Mar-19-15 12:20PM  Stifel executive sells over $1.4 million worth of stock: insider trading for March 10-16 at bizjournals.com
07:20AM  Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche at noodls
07:00AM  Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche PR Newswire
Mar-17-15 09:38AM  VWR Funding, Inc. -- Moody's upgrades VWR's CFR to B1, rates new Euro senior notes B3; outlook stable at Moody's
Mar-12-15 03:14AM  Preliminary Results for the Year Ending 31 December 2014 at noodls
Mar-11-15 07:19AM  China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development at noodls
Mar-05-15 01:21AM  Notice of Results at noodls
Mar-03-15 02:11AM  German Merck sees slight gain in 2015 core profit Reuters
01:14AM  Merck KGaA sees slight increase in 2015 adj core earnings Reuters
Feb-24-15 07:31AM  Cerilliant Introduces Certified Spiking Solutions® of Tryptamines at noodls
07:00AM  Cerilliant Introduces Certified Spiking Solutions® of Tryptamines PR Newswire
Feb-23-15 12:26PM  Sigma-Aldrich (SIAL) Strikes New 52-Week High - Analyst Blog
Feb-18-15 07:30AM  Sigma® Life Science Releases Next-Gen Sequencing Oligos at noodls
07:00AM  Sigma® Life Science Releases Next-Gen Sequencing Oligos PR Newswire
Feb-16-15 01:00AM  Sigma-Aldrich Corporation (SIAL): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
Feb-13-15 10:08AM  Sigma-Aldrich Q4 Earnings Top on Organic Sales Gain - Analyst Blog
Feb-12-15 09:09AM  SIGMA ALDRICH CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:35AM  Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates - Tale of the Tape Zacks
07:07AM  Q4 2014 Sigma-Aldrich Corp Earnings Release - Before Market Open CCBN
06:21AM  Sigma-Aldrich tops Street 4Q forecasts AP
06:00AM  Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales Growth Of 7%. Declares $0.23 Per Share Quarterly Di PR Newswire
Feb-10-15 01:20PM  International Flavors & Fragrances: Earnings Surprise Call? - Analyst Blog Zacks
Feb-09-15 05:07PM  MeadWestvaco spin-off set to maximize shareholder value Market Realist
Feb-06-15 09:07AM  MeadWestvaco sales up $0.2 billion, cost savings on track Market Realist
Feb-03-15 12:10PM  Is Sigma-Aldrich (SIAL) Poised to Beat on Earnings in Q4? - Analyst Blog Zacks
Jan-29-15 07:00AM  Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration PR Newswire
Jan-26-15 02:40PM  Sigma-Aldrich Allies with VIB to Provide Research Tools - Analyst Blog Zacks
Jan-22-15 04:06PM  Sigma-Aldrich named among top sustainable companies worldwide at American City Business Journals
07:00AM  Sigma-Aldrich® and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research Tools PR Newswire
07:00AM  AGTC to Present at Phacilitate Cell & Gene Therapy Forum 2015 GlobeNewswire
Jan-21-15 04:49PM  Sigma-Aldrich® Named One of the Top 100 Most Sustainable Corporations in the World for the Second Consecutive Year PR Newswire
Jan-16-15 02:10PM  Sigma-Aldrich's SAFC Validates Dry Powder Media Unit - Analyst Blog Zacks
Jan-15-15 07:00AM  SAFC's State-of-the-Art Dry Powder Media Manufacturing Facility in Irvine, Scotland, Officially Opens Following Extensive Validation Process PR Newswire
Jan-11-15 06:22PM  Shire to buy NPS for $5.2 billion at USA TODAY
Dec-23-14 03:55PM  Sale of Sigma-Aldrich to Merck gets antitrust approval at American City Business Journals
09:44AM  Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance PR Newswire
Dec-19-14 04:00PM  Year in Review: Sigma-Aldrich acquired by Merck at American City Business Journals
Dec-11-14 07:00AM  Survey of Academic Translational Researchers Highlights Challenges to Reproducible Science PR Newswire
Dec-09-14 11:40AM  Sigma-Aldrich Shareholders Clears Takeover by Merck KGaA Zacks
Dec-08-14 08:30AM  Sigma-Aldrich® Again Named Top Company for Strengthening Communities through Science PR Newswire
Dec-05-14 04:02PM  SIGMA ALDRICH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financial S EDGAR Online
12:30PM  Sigma-Aldrich Stockholders Approve Acquisition By Merck KGaA PR Newswire
Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. The company provides chemical products, reagents, and kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing. The company sells its products to pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies, and hospitals. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REINHARD J PEDRODirectorJun 17Sale139.356,000836,10030,580Jun 18 12:03 PM
Green Eric MarkEVP & President, ResearchMar 12Option Exercise64.3645,7162,942,16355,724Mar 16 05:08 PM
Green Eric MarkEVP & President, ResearchMar 12Sale138.2030,7604,251,03224,964Mar 16 05:08 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecMar 11Option Exercise76.1621,5651,642,46713,549Mar 13 11:48 AM
MILLER GEORGE LLOYDSVP, General Counsel & SecMar 11Sale137.897,095978,3304,539Mar 13 11:48 AM
Bertsch JanEVP & CFOMar 05Option Exercise0.006,000012,752Mar 09 12:20 PM
Marberry MichaelDirectorJan 02Option Exercise0.0068401,057Jan 09 04:42 PM
REINHARD J PEDRODirectorJan 02Option Exercise0.00684036,580Jan 09 04:43 PM
SPATZ D DEANDirectorJan 02Option Exercise0.00684059,640Jan 09 04:44 PM
TOAN BARRETT ADirectorJan 02Option Exercise0.00684029,457Jan 09 04:44 PM
MCCOLLUM LEEDirectorJan 02Option Exercise0.00684013,057Jan 09 04:43 PM
Nash Avi MDirectorJan 02Option Exercise0.00684047,730Jan 09 04:43 PM
PAUL STEVEN MDirectorJan 02Option Exercise0.0068408,257Jan 09 04:43 PM
Bergman Rebecca MDirectorJan 02Option Exercise0.0068405,857Jan 09 04:42 PM
CHURCH GEORGEDirectorJan 02Option Exercise0.0068404,657Jan 09 04:42 PM
SACHDEV RAKESHPresident & CEODec 18Option Exercise48.6111,842575,64043,319Dec 19 01:43 PM
Bertsch JanEVP & CFODec 18Option Exercise71.623,491250,02510,243Dec 19 01:42 PM
Green Eric MarkEVP & President, ResearchDec 18Option Exercise47.5115,900755,33415,318Dec 19 01:42 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 18Option Exercise62.497,950496,79618,136Dec 19 01:42 PM
Bertsch JanEVP & CFODec 17Option Exercise71.628,050576,54114,802Dec 18 03:54 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 17Option Exercise62.491,60099,98411,786Dec 18 04:00 PM
REINHARD J PEDRODirectorDec 17Option Exercise30.1210,000301,20037,820Dec 18 04:01 PM
SACHDEV RAKESHPresident & CEODec 17Option Exercise48.6120,301986,83251,778Dec 18 04:01 PM
KANAN MICHAEL FVP & Corporate ControllerDec 16Option Exercise40.792,600106,0547,438Dec 17 02:41 PM
SACHDEV RAKESHPresident & CEODec 16Option Exercise37.6331,6451,190,77062,041Dec 18 04:01 PM
Nash Avi MDirectorDec 15Option Exercise49.0126,9001,318,30642,773Dec 16 12:21 PM
SACHDEV RAKESHPresident & CEODec 15Option Exercise39.5837,4691,483,02368,946Dec 16 12:21 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 15Option Exercise48.617,943386,10918,129Dec 16 12:21 PM
MILLER GEORGE LLOYDSVP, General Counsel & SecDec 12Option Exercise53.988,970484,20119,156Dec 16 12:21 PM
MCCOLLUM LEEDirectorNov 05Option Exercise30.1210,000301,20022,373Nov 06 02:05 PM
MCCOLLUM LEEDirectorNov 05Sale135.2610,0001,352,58712,373Nov 06 02:05 PM
Green Eric MarkEVP & President, ResearchAug 08Option Exercise0.002,00009,436Aug 12 01:23 PM
KANAN MICHAEL FVP & Corporate ControllerAug 08Option Exercise0.002,00005,506Aug 12 01:23 PM
MILLER KAREN JSVP, Corp Develop & Corp CommJul 28Option Exercise48.617,943386,10912,952Jul 29 01:52 PM
MILLER KAREN JSVP, Corp Develop & Corp CommJul 28Sale103.197,943819,6595,009Jul 29 01:52 PM